Fast-acting edibles can command a premium, but labels such as "nano" do not prove the final product works. The larger operating question is whether the formulation improves taste, shelf stability, manufacturing efficiency, and trust at the same time.
This week we sit down with Kim Sanchez Rael
Fast onset economics
The nano problem
Science/ AI and so much more
Fast-acting cannabis edibles promise a more predictable experience, but the language on the package does not always tell operators what happens in the final product.
Kim Sanchez Rael, President and CEO of Azuca, breaks down what "fast" should mean, why slow-onset edibles still dominate, and how formulation choices affect taste, stability, curing time, shelf life, and production efficiency. She explains why "nano" is often a measurement or marketing label rather than proof of a better consumer outcome, then offers four questions brands should ask any infusion supplier.
The conversation also moves beyond formulation. Kim describes the economics behind fast-acting products, the role of supplier behavior when production is at risk, the case for a single regulatory framework for the cannabis plant, and why operators cannot build a business that depends on an unpredictable regulatory change.
Topics include:
- The consumer value of predictable onset
- Manufacturing tradeoffs in gummy formulation
- What brands should demand from infusion partners
- Why structured quality systems matter
- How Azuca uses AI inside its team and customer experience
Learn more about Azuca and TiME INFUSION® at https://azuca.co/.
Guest: Kim Sanchez Rael, President and CEO, Azuca
Host: Bryan Fields, The Dime
Chapters
- 00:01 Why slow-onset edibles still dominate
- 01:47 The economics of fast acting
- 03:56 Can brands claim "fast"?
- 05:56 Predictability and consumer trust
- 08:06 The retail education gap
- 10:24 How Azuca licensing works
- 14:44 Formulation, cannabinoids, and flavor
- 15:30 When "fast" does not feel fast
- 18:18 Onset, peak, and duration
- 20:01 Manufacturing efficiency R&D
- 23:14 Validating infusion science
- 24:43 Why "nano" is a buzzword
- 27:38 The operational cost of change
- 28:24 Four questions for infusion suppliers
- 30:00 Supplier behavior as brand experience
- 32:31 The Fourth of July production rescue
- 33:48 What cannabis still gets wrong
- 34:15 The One Plant Solution
- 37:04 Policy resistance and incrementalism
- 38:41 AI and "Kimothy"
- 41:21 Quality systems and sustainable math
- 44:58 The question Kim wishes people asked
- 45:45 Where to find Azuca
Our Links
Follow The Dime for more conversations on cannabis business, operations, and international markets.
Share this episode with an operator rethinking their edibles.
Guest Links
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
